Medical Properties Trust (NYSE:MPW) Price Target Cut to $4.50 by Analysts at Wells Fargo & Company

Key Points

• Wells Fargo & Company has lowered its price target for Medical Properties Trust from $5.00 to $4.50, maintaining an "underweight" rating on the stock.
• The current consensus rating for Medical Properties Trust is "Hold," with a consensus target price of $5.58.
• The company reported earnings per share of $0.14 for the last quarter, missing analysts' expectations, and its revenue decreased by 9.8% year-over-year.

Medical Properties Trust (NYSE:MPW - Get Free Report) had its price target lowered by investment analysts at Wells Fargo & Company from $5.00 to $4.50 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an "underweight" rating on the real estate investment trust's stock. Wells Fargo & Company's price objective suggests a potential upside of 4.05% from the company's previous close.

MPW has been the topic of several other research reports. Zacks Research raised shares of Medical Properties Trust from a "strong sell" rating to a "hold" rating in a research note on Wednesday, August 20th. Royal Bank Of Canada reduced their price objective on shares of Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating on the stock in a research note on Monday, June 30th. Finally, Wall Street Zen downgraded shares of Medical Properties Trust from a "hold" rating to a "sell" rating in a research note on Saturday, July 5th. Two investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Medical Properties Trust currently has a consensus rating of "Hold" and a consensus target price of $5.58.

Medical Properties Trust Price Performance

Shares of NYSE MPW traded up $0.01 on Wednesday, hitting $4.33. The company's stock had a trading volume of 922,791 shares, compared to its average volume of 10,394,993. The company has a debt-to-equity ratio of 2.00, a current ratio of 2.76 and a quick ratio of 2.76. The company has a market capitalization of $2.60 billion, a price-to-earnings ratio of -1.81 and a beta of 1.28. The stock has a 50 day moving average of $4.24 and a 200-day moving average of $4.88. Medical Properties Trust has a 12-month low of $3.51 and a 12-month high of $6.55.

Medical Properties Trust (NYSE:MPW - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.01). The firm had revenue of $240.36 million for the quarter, compared to analysts' expectations of $231.90 million. Medical Properties Trust had a negative net margin of 155.20% and a negative return on equity of 28.80%. The business's quarterly revenue was down 9.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.23 EPS. As a group, research analysts predict that Medical Properties Trust will post 0.78 EPS for the current year.

Hedge Funds Weigh In On Medical Properties Trust

Hedge funds have recently made changes to their positions in the business. Charles Schwab Investment Management Inc. grew its holdings in Medical Properties Trust by 13.4% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 10,020,568 shares of the real estate investment trust's stock valued at $60,424,000 after purchasing an additional 1,182,028 shares in the last quarter. Allianz Asset Management GmbH grew its holdings in Medical Properties Trust by 43.2% during the 1st quarter. Allianz Asset Management GmbH now owns 7,134,629 shares of the real estate investment trust's stock valued at $43,022,000 after purchasing an additional 2,152,861 shares in the last quarter. Northern Trust Corp grew its holdings in Medical Properties Trust by 1.5% during the 1st quarter. Northern Trust Corp now owns 6,404,674 shares of the real estate investment trust's stock valued at $38,620,000 after purchasing an additional 95,525 shares in the last quarter. Wilsey Asset Management Inc. grew its holdings in Medical Properties Trust by 6.1% during the 2nd quarter. Wilsey Asset Management Inc. now owns 4,927,568 shares of the real estate investment trust's stock valued at $21,238,000 after purchasing an additional 281,591 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Medical Properties Trust by 11.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,086,848 shares of the real estate investment trust's stock valued at $24,644,000 after purchasing an additional 410,374 shares in the last quarter. Hedge funds and other institutional investors own 71.79% of the company's stock.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.